Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ: IRTC )

108.33 +1.34 (+1.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) Investors
From Kirby McInerney LLP
Via Business Wire
IRTC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead the iRhythm Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
IRHYTHM TECHNOLOGIES, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. (NASDAQ: IRTC)
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
From iRhythm
Via GlobeNewswire
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services... 
From iRhythm
Via GlobeNewswire
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
Study findings from a collaboration with Duke Health found that a model that incorporates ECG data from long-term continuous monitoring resulted in more accurate prediction of heart failure... 
From iRhythm
Via GlobeNewswire
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
From iRhythm
Via GlobeNewswire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into iRhythm Technologies, Inc. (IRTC)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
4 Stocks With Huge Cash Holdings at Silicon Valley Bank
How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day? 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few 
Via Spotlight Growth
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030
Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart.... 
Via FinancialNewsMedia
Global Supplier of Non-Invasive Cardiac Monitoring Systems Expanding Via New Partnerships & OTCQB Uplisting Efforts: CB Scientific Stock Symbol: CBSC
Via Get News
Topics Supply Chain
Exposures Product Safety Supply Chain
Atrial Fibrillation Market Is Expected To Reach  $11.123 Billion At A CAGR 11.2 % Through 2023
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of... 
Via FinancialNewsMedia
Topics Death
Exposures Death
Why A.I. Is About To Trigger The Next Great Medical Breakthrough
FN Media Group Presents Oilprice.com Market Commentary London – October 21, 2021 – The healthcare industry is one of the fastest growing in the world, but today, it’s seeing a major disruption. With... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025
Via FinancialNewsMedia
NASDAQ:IRTC Long Term Investor Alert: Investigation of Potential Wrongdoing at iRhythm Technologies, Inc.
San Diego, CA -- (SBWIRE) -- 05/14/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of iRhythm Technologies, Inc. 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.